A new generation of treatments for Type 1 diabetes is likely to come from within our own bodies. We know that a wide range of cell types have the ability to regenerate. Although some of these cells are found outside the pancreas, their regenerative capacity can be harnessed to replenish the insulin-producing
islet cells in the pancreas that are destroyed in diabetes. In this article, Denise Faustman looks at the potential benefits and pitfalls of four biologically based therapies, all of which take advantage of the body’s own capacity for healing and renewal.